RESULTS OF RADIATION-THERAPY IN EARLY GLOTTIC CARCINOMA (T1, T2 N0)

被引:6
|
作者
STEIN, M
ROSENBLATT, E
KUTEN, A
COHEN, Y
机构
关键词
D O I
10.1002/jso.2930400308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:173 / 176
页数:4
相关论文
共 50 条
  • [1] Endocavitary contact radiation therapy for ultrasonographically staged T1 N0 and T2 N0 rectal cancer
    Christoforidis, D.
    McNally, M. P.
    Jarosek, S. L.
    Madoff, R. D.
    Finne, C. O.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (04) : 430 - 436
  • [2] Photodynamic Therapy Outcome for T1/T2 N0 Oral Squamous Cell Carcinoma
    Jerjes, Waseem
    Upile, Tahwinder
    Hamdoon, Zaid
    Mosse, Charles Alexander
    Morcos, Mira
    Hopper, Colin
    [J]. LASERS IN SURGERY AND MEDICINE, 2011, 43 (06) : 463 - 469
  • [3] Establishing current UK radiotherapy treatment volumes and dose for early glottic larynx cancer (T1/T2 N0)
    Chennupati, Jyothsna
    Beasley, Matthew
    Al-Booz, Hoda
    [J]. CLINICAL ONCOLOGY, 2019, 31 : E8 - E8
  • [4] DEFINITIVE RADIOTHERAPY FOR T1 N0 SQUAMOUS CELL CARCINOMA OF THE GLOTTIC LARYNX
    Cacicedo, J.
    Casquero Ocio, F.
    Diaz Gavela, A. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S312 - S313
  • [5] Radiation therapy in early carcinoma of the glottic larynx T1N0M0
    [J]. Int J Radiat Oncol Biol Phys, 5 (1211):
  • [6] Radiation therapy in early carcinoma of the glottic larynx T1N0M0
    Medini, E
    Medini, A
    Gapany, M
    Levitt, SH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05): : 1211 - 1213
  • [7] QUANTITATIVE VOICE PHYSIOLOGY ANALYSIS AFTER RADIATION-THERAPY FOR T1 GLOTTIC CARCINOMA
    DWORKIN, JP
    AREF, AM
    FONTANESI, J
    DEVI, SB
    DENTON, L
    [J]. RADIOLOGY, 1995, 197 : 428 - 428
  • [8] Objective voice evaluation after radiation therapy for T1 and T2 glottic tumors
    Carrara-De Angelis, E
    Santos, CR
    Cervantes, O
    Kowalski, LP
    Abrahao, M
    Fúria, C
    Brandao, AP
    Martins, N
    [J]. 1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 341 - 343
  • [9] ARE THE CURRENT MANAGEMENT STRATEGIES FOR T1/T2 N0 OESOPHAGEAL CANCER OPTIMAL?
    Evans, J.
    Pande, R.
    Beardsmore, D.
    Corless, D.
    Crisp, W.
    Cheruvu, C.
    [J]. GUT, 2012, 61 : A262 - A262
  • [10] ARE THE CURRENT MANAGEMENT STRATEGIES FOR T1/T2 N0 OESOPHAGEAL CANCER OPTIMAL?
    Evans, R.
    Evans, J. P.
    Kirby, G.
    Curran, F.
    Cheruvu, C. V. N.
    [J]. GUT, 2015, 64 : A475 - A475